Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients
A Phase IIa Efficacy and Safety Trial With Intravenous S95011 in Primary Sjögren's Syndrome Patients: An International, Multicentre, Randomised, Double-blind, Placebo-controlled Study A Phase IIa Efficacy and Safety Trial With Intravenous S95011in Primary Sjögren's Syndrome Patients: ...
Efficacy and safety of S95011 in primary Sjögren’s Syndrome patients
A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients. An international, multicentre, randomised, double-blind, placebo-controlled study A phase IIa efficacy and safety trial with intravenous S95011in primary Sjögren’s Syndrome patients. ...
Efficacy and safety of S95011 in primary Sjögren’s Syndrome patients
A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients. An international, multicentre, randomised, double-blind, placebo-controlled study A phase IIa efficacy and safety trial with intravenous S95011in primary Sjögren’s Syndrome patients. ...
Efficacy and safety of S95011 in primary Sjögren’s Syndrome patients
A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients. An international, multicentre, randomised, double-blind, placebo-controlled study A phase IIa efficacy and safety trial with intravenous S95011in primary Sjögren’s Syndrome patients. ...